International cooperation to address
and counter the world drug problem
A/RES/74/178
resolutions adopted by the Commission on Narcotic Drugs and the outcome document
of the thirtieth special session of the General Assembly;
100. Expresses concern regarding the overall financial situation of the United
Nations Office on Drugs and Crime, emphasizes the need to provide the Office with
adequate, predictable and stable resources and to ensure their cost -effective
utilization, and requests the Secretary-General to continue to report, within existing
reporting obligations, on the financial situation of the Office and to continue to ensure
that the Office has sufficient resources to carry out its mandates fully and effectively;
101. Encourages Member States and the United Nations Office on Drugs and
Crime to continue to address the above-mentioned issues within the mandate of the
standing open-ended intergovernmental working group on improving the governance
and financial situation of the Office in order for the Office to fulfil its mand ate
effectively, efficiently and with the appropriate resources;
102. Encourages the Commission on Narcotic Drugs, as the principal
policymaking organ of the United Nations on matters of international drug control
and as the governing body of the drug programme of the United Nations Office on
Drugs and Crime, and the International Narcotics Control Board to continue to
strengthen their work on the control of precursors and other chemicals used in the
illicit manufacture of narcotic drugs and psychotropic s ubstances;
103. Calls upon Member States to strengthen national and international action
to address the emerging challenge of new psychoactive substances, including their
adverse health consequences, and the evolving threat of amphetamine -type
stimulants, including methamphetamine, underscores the importance of enhancing
information-sharing and early warning networks, developing appropriate national
legislative, prevention and treatment models and supporting scientific evidence -based
review and scheduling of the most prevalent, persistent and harmful substances, and
notes the importance of preventing the diversion and misuse of pharmaceuticals
containing narcotic drugs and psychotropic substances and precursors, while ensuring
their availability for legitimate purposes;
104. Urges States that have not done so to consider ratifying or acceding to, and
States parties to implement, as a matter of priority, all the provisions of the Single
Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol, 6 the
Convention on Psychotropic Substances of 1971, 7 the United Nations Convention
against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988, the
United Nations Convention against Transnational Organized Crime and the Protocols
thereto 23 and the United Nations Convention against Corruption; 24
105. Requests the United Nations Office on Drugs and Crime to continue to
provide, in close collaboration with the International Narcotics Control Board, as
appropriate, adequate support and technical assistance to Governments in all regions
so as to enable them to implement and fully meet their obligations under conventions
and give adequate follow-up to subsequent resolutions of the Commission on Narcotic
Drugs, the Economic and Social Council and the General Assembly, including for the
strengthening of regulatory authorities and controls, provision of information and
fulfilment of reporting requirements, and urges donors to contribute to the Office for
those purposes;
106. Takes note of the resolutions adopted by the Commission on Narcotic
Drugs at its sixty-second session 2 and of the World Drug Report 2019;
__________________
23
24
20/23
United Nations, Treaty Series, vols. 2225, 2237, 2241 and 2326, No. 39574.
Ibid., vol. 2349, No. 42146.
19-22335
Select target paragraph3
Connect to a paragraph
Connect to an entity
Disable highlights
Add to table of contents